I-Mab

I-Mab (IMAB) Financials

$4.630

-0.010 (-0.22%)At close

IMAB Profitability and Margins

Evaluating the bottom line, I-Mab maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -18.46%, provide a clear picture of how effectively IMAB converts its operational activities into shareholder value.

IMAB Comparative Benchmarking

In the context of the broader market, IMAB competes directly with industry leaders such as VNDA and ACIU. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, IMAB's gross margin of N/A stands against VNDA's 89.02% and ACIU's 100.00%. Such benchmarking helps identify whether I-Mab is trading at a premium or discount relative to its financial performance.

Financials

FY2025Q2
0.00
Total Revenue
FY2025Q2
YoY:
-58.49%
-7.11M
Operating Profit
FY2025Q2
YoY:
-38.45%
-5.50M
Net Income after Tax
FY2025Q2
YoY:
-121.43%
-0.03
EPS - Diluted

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started